BEVERLY JCG LTD. Financials Beverly JCG Ltd. Singapore S.E.
Equities
9QX
SGXE87511171
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.024 SGD | -.--% |
|
-14.29% | -52.00% |
| 04-25 | Beverly JCG Enters Debt Capitalization Agreement; Shares Surge 8% | MT |
| 04-18 | Beverly JCG to Pay Sponsor with New Shares Worth SG$75,000 | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 8.813 | 46.15 | 31.63 | 18.66 | 19.68 | 29.11 |
| Enterprise Value (EV) 1 | 10.66 | 48.36 | 35.18 | 20.9 | 22.79 | 31.36 |
| P/E ratio | -4.32 x | -12.1 x | -6.67 x | -5 x | -9.2 x | -10.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 5.32 x | 14.5 x | 5.81 x | 2.08 x | 1.87 x | 3.62 x |
| EV / Revenue | 6.43 x | 15.2 x | 6.46 x | 2.33 x | 2.17 x | 3.9 x |
| EV / EBITDA | -8.03 x | -18.7 x | -9.13 x | -9.4 x | -18.5 x | -17.6 x |
| EV / FCF | 6.48 x | -12.8 x | -11.2 x | 6.28 x | -105 x | -69.4 x |
| FCF Yield | 15.4% | -7.81% | -8.91% | 15.9% | -0.96% | -1.44% |
| Price to Book | -1.61 x | 6.82 x | 9.59 x | -86.8 x | -14.8 x | 219 x |
| Nbr of stocks (in thousands) | 88,128 | 307,678 | 316,299 | 373,254 | 393,628 | 582,156 |
| Reference price 2 | 0.1000 | 0.1500 | 0.1000 | 0.0500 | 0.0500 | 0.0500 |
| Announcement Date | 19-04-14 | 20-04-15 | 21-06-14 | 22-04-13 | 23-04-13 | 24-04-12 |
1SGD in Million2SGD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.658 | 3.179 | 5.446 | 8.974 | 10.51 | 8.041 |
| EBITDA 1 | -1.328 | -2.582 | -3.852 | -2.223 | -1.234 | -1.778 |
| EBIT 1 | -1.376 | -2.788 | -5.292 | -3.328 | -2.32 | -2.425 |
| Operating Margin | -82.99% | -87.7% | -97.17% | -37.08% | -22.07% | -30.16% |
| Earnings before Tax (EBT) 1 | -1.972 | -3.244 | -5.13 | -3.014 | -2.429 | -2.509 |
| Net income 1 | -2.038 | -3.088 | -4.25 | -2.5 | -2.115 | -2.218 |
| Net margin | -122.92% | -97.14% | -78.04% | -27.86% | -20.12% | -27.58% |
| EPS 2 | -0.0231 | -0.0124 | -0.0150 | -0.0100 | -0.005432 | -0.004935 |
| Free Cash Flow 1 | 1.645 | -3.778 | -3.133 | 3.326 | -0.2178 | -0.452 |
| FCF margin | 99.19% | -118.85% | -57.53% | 37.06% | -2.07% | -5.62% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19-04-14 | 20-04-15 | 21-06-14 | 22-04-13 | 23-04-13 | 24-04-12 |
1SGD in Million2SGD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.85 | 2.21 | 3.55 | 2.24 | 3.11 | 2.26 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -1.395 x | -0.8544 x | -0.9216 x | -1.006 x | -2.519 x | -1.269 x |
| Free Cash Flow 1 | 1.64 | -3.78 | -3.13 | 3.33 | -0.22 | -0.45 |
| ROE (net income / shareholders' equity) | 46.6% | -215% | -80.2% | -147% | 419% | 467% |
| ROA (Net income/ Total Assets) | -25.4% | -18.8% | -23% | -19.8% | -18.5% | -20.9% |
| Assets 1 | 8.035 | 16.43 | 18.5 | 12.64 | 11.45 | 10.61 |
| Book Value Per Share 2 | -0.0600 | 0.0200 | 0.0100 | -0 | -0 | 0 |
| Cash Flow per Share 2 | 0.0200 | 0 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.01 | 0.08 | 0.54 | 0.33 | 0.11 | 0.09 |
| Capex / Sales | 0.48% | 2.58% | 9.99% | 3.62% | 1.08% | 1.16% |
| Announcement Date | 19-04-14 | 20-04-15 | 21-06-14 | 22-04-13 | 23-04-13 | 24-04-12 |
1SGD in Million2SGD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +14.08% | 81.84B | |
| -30.26% | 70.69B | |
| +9.37% | 29.03B | |
| -12.13% | 16.97B | |
| -0.36% | 16.83B | |
| -1.35% | 15.28B | |
| +5.90% | 12.41B | |
| +36.03% | 12.26B | |
| -4.20% | 11.86B |
- Stock Market
- Equities
- 9QX Stock
- 9QX Stock
- Financials Beverly JCG Ltd.
